Novo released new evidence that its experimental CagriSema injection can improve upon the weight loss with its blockbuster GLP-1 obesity injection, Wegovy.
A prominent French researcher believes there is a direct link between the loss of smell and the rise in obesity and type 2 diabetes.
Thanks to new research, we’re learning more about a twist in the relationship between body weight and cancer survival that seems to defy conventional wisdom.
Nearly 3 in 4 adults undergoing metabolic bariatric surgery (MBS) at 4 international centers met criteria for clinical obesity under a new disease-based framework, despite body mass index (BMI) levels .
Compared with individuals who are normal weight, those with overweight or obesity have lower mortality when diagnosed with dementia.
Clinical obesity increased among U.
A landmark 24-year study shows that individuals who are overweight or obese at the time of dementia diagnosis face up to a 27% lower risk of death than normal-weight peers.
Based on sessions presented at CHEST 2026, tirzepatide and semaglutide demonstrate significant clinical benefits in obesity and comorbid obstructive sleep apnea.
While GLP-1 medicines have become synonymous with weight loss, at least one expert thinks amylin would have been the go-to target if biopharma had been focused on the blockbuster indication 10 years .
Top obesity support organizations like Obesity Action Coalition, American Obesity Foundation, and Overeaters Anonymous help those with obesity connect with others and access resources for a healthier .
Eli Lilly spent most of its 150-year history as a quiet insulin maker before a single drug reshuffled the entire obesity market and turned a modest stake into a fortune that left the S&P 500 in the .
Consumer Commission Relies On Doctors’ Certificates To Reject Insurer’s Defence .